176 results on '"Reekie, Joanne"'
Search Results
2. All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort study
3. Development of antibody levels and subsequent decline in individuals with vaccine induced and hybrid immunity to SARS-CoV-2
4. Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
5. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
6. Cross‐sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort
7. Characteristics associated with serological COVID-19 vaccine response and durability in an older population with significant comorbidity: the Danish Nationwide ENFORCE Study
8. Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
9. Chest x-ray imaging score is associated with severity of COVID-19 pneumonia: the MBrixia score
10. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients
11. Predicting type 2 diabetes risk before and after solid organ transplantation using polygenic scores in a Danish cohort
12. SARS-CoV-2 vaccine-induced antibodies protect against Omicron breakthrough infection
13. P629: THE CLL TREATMENT INFECTION MODEL – CLINICAL PROSPECTIVE VALIDATION AS PART OF THE PREVENT-ACALL TRIAL
14. Prevalence and Outcomes for Heavily Treatment-Experienced Individuals Living With Human Immunodeficiency Virus in a European Cohort
15. Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)
16. Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)
17. Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV
18. Cohort Profile:The Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 vaccines (ENFORCE)
19. Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV
20. Trends in underlying causes of death in solid organ transplant recipients between 2010 and 2020: Using the CLASS method for determining specific causes of death
21. Changes in body mass index and clinical outcomes after initiation of contemporary antiretroviral regimens
22. Development and Validation of a Risk Score for Post-Transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
23. Added Value of Reanalysis of Whole Exome- and Whole Genome Sequencing Data From Patients Suspected of Primary Immune Deficiency Using an Extended Gene Panel and Structural Variation Calling
24. Posttransplantation Diabetes Mellitus Among Solid Organ Recipients in a Danish Cohort
25. Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
26. Association between ten-eleven methylcytosine dioxygenase 2 genetic variation and viral load in people with HIV.
27. Donor Lymphocyte Infusion Is a Feasible Way to Improve Survival in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Who Relapse after Allogeneic Stem Cell Transplantation
28. 29. Sustained Recovery in Patients Admitted to Hospital With COVID-19
29. 23. Development and Validation of a Risk Score for Post-transplant Lymphoproliferative Disorders among Solid Organ Transplant Recipients
30. Incidence and risk factors for suicide, death due to substance use, and violent/accidental death in people with HIV
31. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
32. The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies
33. 252. Increased incidence rates of positive blood cultures shortly after chemotherapy treatment initiation among individuals treated for solid malignant tumours
34. 1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
35. 1079. The Risk of Cytomegalovirus (CMV) Infection and Recurrence Among Solid Organ Transplant Recipients
36. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy
37. Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata
38. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
39. Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
40. 2613. The Epidemiology of Respiratory Syncytial Virus (RSV) in People with Immune Dysfunction Seen at a Tertiary Hospital Between 2010 and 2017
41. 2569. The Gut Microbiome and Acute Graft vs. Host Disease Risk in Hematopoietic Stem Cell Transplantation Recipients
42. Does less frequent routine monitoring of patients on a stable, fully suppressed cART regimen lead to an increased risk of treatment failure?
43. Genetic, environmental and gender influences on attachment disorder behaviours
44. The association of human leukocyte antigen alleles with clinical disease progression in HIV-positive cohorts with varied treatment strategies.
45. Benchmarking HIV health care: from individual patient care to health care evaluation. An example from the EuroSIDA study
46. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation
47. Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients
48. 1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The CSRFENCE Score
49. Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score
50. The Incidence of AIDS-Defining Illnesses at a Current CD4 Count ≥200 Cells/µL in the Post-Combination Antiretroviral Therapy Era
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.